2-72888457-A-G

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong

The NM_003124.5(SPR):​c.448A>G​(p.Arg150Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000855 in 1,613,918 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).

Frequency

Genomes: 𝑓 0.000059 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000088 ( 0 hom. )

Consequence

SPR
NM_003124.5 missense

Scores

4
10
5

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:9

Conservation

PhyloP100: 3.95
Variant links:
Genes affected
SPR (HGNC:11257): (sepiapterin reductase) This gene encodes an aldo-keto reductase that catalyzes the NADPH-dependent reduction of pteridine derivatives and is important in the biosynthesis of tetrahydrobiopterin (BH4). Mutations in this gene result in DOPA-responsive dystonia due to sepiaterin reductase deficiency. A pseudogene has been identified on chromosome 1. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.892
PP5
Variant 2-72888457-A-G is Pathogenic according to our data. Variant chr2-72888457-A-G is described in ClinVar as [Pathogenic]. Clinvar id is 12941.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPRNM_003124.5 linkuse as main transcriptc.448A>G p.Arg150Gly missense_variant 2/3 ENST00000234454.6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SPRENST00000234454.6 linkuse as main transcriptc.448A>G p.Arg150Gly missense_variant 2/31 NM_003124.5 P1
SPRENST00000498749.1 linkuse as main transcriptn.393A>G non_coding_transcript_exon_variant 2/33

Frequencies

GnomAD3 genomes
AF:
0.0000591
AC:
9
AN:
152194
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000103
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000557
AC:
14
AN:
251238
Hom.:
0
AF XY:
0.0000221
AC XY:
3
AN XY:
135754
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000203
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000883
AC:
129
AN:
1461724
Hom.:
0
Cov.:
31
AF XY:
0.0000839
AC XY:
61
AN XY:
727138
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000246
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000953
Gnomad4 OTH exome
AF:
0.000149
GnomAD4 genome
AF:
0.0000591
AC:
9
AN:
152194
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.0000241
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000103
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000428
Hom.:
0
Bravo
AF:
0.0000567
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000576
AC:
7

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Dopa-responsive dystonia due to sepiapterin reductase deficiency Pathogenic:5
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityJan 27, 2022- -
Pathogenic, no assertion criteria providedliterature onlyOMIMDec 12, 2006- -
Pathogenic, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsJan 05, 2022- -
Pathogenic, criteria provided, single submitterclinical testingMolecular Genetics, Royal Melbourne HospitalAug 04, 2022This sequence change in SPR is predicted to replace arginine with glycine at codon 150, p.(Arg150Gly). The arginine residue is highly conserved (100 vertebrates, UCSC), and is located in a beta-strand. There is a large physicochemical difference between arginine and glycine. The highest population minor allele frequency in gnomAD v2.1 is 0.02% (7/35,402 alleles) in the Latino/admixed American population, which is consistent with a recessive condition. This variant has been detected in at least ten individuals with sepiapterin reductase deficiency. Of those individuals, two individuals were homozygous and 8 were compound heterozygous for the variant and a pathogenic or likely pathogenic variant and one of those was confirmed in trans by parental testing (PMID: 11443547, 17159114, 19491146, 22522443). The variant demonstrates deficient enzyme activity in an in vitro functional assay (PMID: 11443547). Multiple lines of computational evidence predict a deleterious effect for the missense substitution (5/6 algorithms). Based on the classification scheme RMH Modified ACMG Guidelines v1.5.1, this variant is classified as PATHOGENIC. Following criteria are met: PM3_VeryStrong, PS3_Supporting, PM2_Supporting, PP3. -
Pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpNov 15, 2019Variant summary: SPR c.448A>G (p.Arg150Gly) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.6e-05 in 251238 control chromosomes (gnomAD). The variant, c.448A>G, has been reported in the literature in multiple homozygous- and compound heterozygous individuals affected with Sepiapterin reductase deficiency (e.g. Bonafe_2001, Clot_2009, Friedman_2012). These data indicate that the variant is very likely to be associated with disease. At least one publication, Bonafe_2001, reported that the variant almost completely abolished the enzyme activity. Three ClinVar submitters (evaluation after 2014) cite the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
not provided Pathogenic:2
Pathogenic, criteria provided, single submitterclinical testingGeneDxMay 11, 2023Published functional studies demonstrate absent sepiapterin reductase enzyme activity in vitro (Bonafe et al., 2001); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24212389, 16917893, 19491146, 28516087, 21677200, 11443547, 17159114, 27080360, 26123188, 23430877, 22522443, 21431957, 33977029, 30799092, 31589614) -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenApr 01, 2019- -
SPR-related disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesDec 21, 2023The SPR c.448A>G variant is predicted to result in the amino acid substitution p.Arg150Gly. This variant has been reported to be causative for dopa-responsive dystonia due to sepiapterin reductase deficiency (Bonafé et al. 2001. PubMed ID: 11443547; Leuzzi et al. 2013. PubMed ID: 24212389; Thibert et al. 2012. PubMed ID: 23430877). This variant is reported in 0.020% of alleles in individuals of Latino descent in gnomAD. This variant is interpreted as pathogenic. -
Dystonic disorder Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeJul 25, 2022This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 150 of the SPR protein (p.Arg150Gly). This variant is present in population databases (rs104893665, gnomAD 0.02%). This missense change has been observed in individual(s) with sepiapterin reductase deficiency (PMID: 11443547, 21431957, 21677200, 23430877, 24212389). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 12941). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects SPR function (PMID: 11443547). For these reasons, this variant has been classified as Pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Uncertain
0.15
D
BayesDel_noAF
Pathogenic
0.27
CADD
Pathogenic
26
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.77
D
Eigen
Benign
-0.0085
Eigen_PC
Benign
-0.027
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.90
D
M_CAP
Uncertain
0.22
D
MetaRNN
Pathogenic
0.89
D
MetaSVM
Uncertain
-0.16
T
MutationAssessor
Benign
-0.31
N
MutationTaster
Benign
1.0
A
PrimateAI
Benign
0.43
T
PROVEAN
Pathogenic
-5.8
D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.010
D
Polyphen
1.0
D
Vest4
0.73
MVP
0.92
MPC
1.4
ClinPred
0.75
D
GERP RS
3.1
Varity_R
0.87
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs104893665; hg19: chr2-73115586; API